Peanut Consumption Linked to Lower Type 2 Diabetes Risk via Lipid Changes
New research identifies specific blood fat signatures associated with peanut intake and diabetes prevention.
1Peanut Intake and Lipidomics
Researchers led by Dr. Rosa Lamuela-Raventós investigated how daily peanut consumption alters blood fat profiles. By integrating data from the ARISTOTLE clinical trial and the EPIC-Potsdam population cohort, the team identified a unique lipid signature. This study specifically examined the impact of peanuts on circulating fats and subsequent cardiometabolic health outcomes.
2Clinical Trial Methodology
The study involved 63 healthy young adults in Barcelona who consumed 25 grams of roasted peanuts, 32 grams of peanut butter, or a control butter daily for six months. Blood analysis revealed that these diets significantly altered 51 groups of fats, particularly those containing very long-chain saturated fatty acids found in peanuts.
3Sphingolipids and Metabolic Changes
The observed changes in the blood lipidome were primarily concentrated within the sphingolipids family, which includes ceramides. These specific fat alterations formed the basis of a peanut lipidomic signature score. This score serves as a measurable biomarker that can be calculated from blood samples to track dietary intake and potential health effects.
4Diabetes Risk Correlation
When applied to the EPIC-Potsdam study, which tracked 774 individuals who developed type 2 diabetes, the researchers found a meaningful correlation. Each one-standard-deviation increase in the peanut lipidomic score was associated with an 11% lower risk of developing type 2 diabetes, suggesting a protective effect linked to specific dietary fat intake.
5Role of Body Mass Index
The study revealed that the association between peanut consumption and lower diabetes risk was largely attenuated after adjusting for body mass index. This finding suggests that peanuts may influence diabetes risk primarily by affecting body weight. However, the researchers describe this specific analysis as hypothesis-generating, noting that the current uncertainty remains wide.
6Cardiovascular Disease Findings
While the study established a clear link between the peanut-derived lipid signature and a reduced risk of type 2 diabetes, the results for cardiovascular disease were different. The researchers found no significant association between the peanut lipidomic score and cardiovascular disease outcomes, indicating that the protective benefits may be specific to metabolic health.
7Nutritional Implications
These findings support the inclusion of peanuts as a source of healthy fats within a balanced diet designed to protect cardiometabolic health. By identifying how peanuts influence the circulating lipidome, the research provides a biological mechanism for how dietary choices can potentially mitigate the risk of chronic metabolic conditions like diabetes.
8Research Publication Context
The study, authored by Inés Domínguez-López and colleagues, was published in The American Journal of Clinical Nutrition in 2026. It highlights the importance of using integrated data from both controlled clinical trials and large-scale population cohorts to better understand the complex relationship between specific food sources, blood lipid profiles, and long-term health.